[go: up one dir, main page]

NO20004807L - 3´,3´-N-bis-substituerte makrolid LHRH antagonister - Google Patents

3´,3´-N-bis-substituerte makrolid LHRH antagonister

Info

Publication number
NO20004807L
NO20004807L NO20004807A NO20004807A NO20004807L NO 20004807 L NO20004807 L NO 20004807L NO 20004807 A NO20004807 A NO 20004807A NO 20004807 A NO20004807 A NO 20004807A NO 20004807 L NO20004807 L NO 20004807L
Authority
NO
Norway
Prior art keywords
bis
lhrh antagonists
substituted macrolide
macrolide lhrh
substituted
Prior art date
Application number
NO20004807A
Other languages
English (en)
Other versions
NO20004807D0 (no
Inventor
Daryl R Sauer
Fortuna Haviv
John Randolph
Nicholas A Mort
Christopher Robin Dalton
Milan Bruncko
Michele A Kaminski
Bradley W Crawford
Lisa Marie Frey
Jonathan Greer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20004807D0 publication Critical patent/NO20004807D0/no
Publication of NO20004807L publication Critical patent/NO20004807L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20004807A 1998-03-27 2000-09-26 3´,3´-N-bis-substituerte makrolid LHRH antagonister NO20004807L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/049,458 US5972898A (en) 1998-03-27 1998-03-27 3',3-N-bis-substituted macrolide LHRH antagonists
PCT/US1999/006250 WO1999050276A1 (en) 1998-03-27 1999-03-22 3',3'-n-bis-substituted macrolide lhrh antagonists

Publications (2)

Publication Number Publication Date
NO20004807D0 NO20004807D0 (no) 2000-09-26
NO20004807L true NO20004807L (no) 2000-11-24

Family

ID=21959914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004807A NO20004807L (no) 1998-03-27 2000-09-26 3´,3´-N-bis-substituerte makrolid LHRH antagonister

Country Status (18)

Country Link
US (1) US5972898A (no)
EP (1) EP1066307A1 (no)
JP (1) JP2002509938A (no)
KR (1) KR20010034699A (no)
CN (1) CN1303389A (no)
AU (1) AU3197599A (no)
BG (1) BG104827A (no)
BR (1) BR9909121A (no)
CA (1) CA2325519A1 (no)
HU (1) HUP0102522A3 (no)
IL (1) IL138220A0 (no)
NO (1) NO20004807L (no)
NZ (1) NZ506622A (no)
PL (1) PL343152A1 (no)
SK (1) SK13982000A3 (no)
TR (1) TR200002766T2 (no)
WO (1) WO1999050276A1 (no)
ZA (1) ZA200005030B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
AU6381201A (en) * 2000-03-28 2001-10-08 Biochemie Gmbh Granulated particles with masked taste
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
KR100876538B1 (ko) 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법
JP5314835B2 (ja) 2000-11-15 2013-10-16 昌雄 菅又 子宮内膜症の予防又は治療薬
AU2003202115A1 (en) 2002-02-12 2003-09-04 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
CA2489252A1 (en) 2002-06-13 2003-12-24 Pfizer Inc. Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
WO2010141932A1 (en) 2009-06-05 2010-12-09 Link Medicine Corporation Aminopyrrolidinone derivatives and uses thereof
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
EP0215355B1 (en) * 1985-08-31 1994-04-06 Kitasato Kenkyusho Erythromycin derivative and process for preparing the same
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
WO1992009614A1 (en) * 1990-11-28 1992-06-11 Taisho Pharmaceutical Co., Ltd. 6-o-methylerythromycin a derivative
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EA000992B1 (ru) * 1995-12-14 2000-08-28 Мерк Энд Ко., Инк. Антагонисты гормона, высвобождающего гонадотропин
CA2253330C (en) * 1996-05-07 2006-07-25 Abbott Laboratories 6-o-substituted erythromycin compounds and method for making same

Also Published As

Publication number Publication date
US5972898A (en) 1999-10-26
BR9909121A (pt) 2000-12-19
TR200002766T2 (tr) 2001-01-22
JP2002509938A (ja) 2002-04-02
BG104827A (en) 2001-07-31
NZ506622A (en) 2003-03-28
ZA200005030B (en) 2001-08-10
PL343152A1 (en) 2001-07-30
SK13982000A3 (sk) 2001-04-09
CN1303389A (zh) 2001-07-11
EP1066307A1 (en) 2001-01-10
CA2325519A1 (en) 1999-10-07
KR20010034699A (ko) 2001-04-25
IL138220A0 (en) 2001-10-31
HUP0102522A2 (hu) 2001-10-28
HUP0102522A3 (en) 2003-08-28
NO20004807D0 (no) 2000-09-26
AU3197599A (en) 1999-10-18
WO1999050276A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
MA26831A1 (fr) Derives de benzodiazepine."
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
ID24583A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena tersubstitusi
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
NO20004807L (no) 3´,3´-N-bis-substituerte makrolid LHRH antagonister
DE69812805D1 (de) Fungizide 2,6,6'-Trimethylbenzophenone
DK1149106T3 (da) 4,5-azolo-oxindoler
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
ID26368A (id) Turunan-turunan 2 deoksi higromisin
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DK1066304T3 (da) Macrolid-LHRH-antagonister
ES1041880Y (es) Puya de picador.
HK1036283A (en) 3',3'-n-bis-substituted macrolide lhrh antagonists
ES1042496Y (es) "pilona sumible".
FI980405A0 (fi) Industriellt, kontinuerligt foerfarande foer framstaellning av "gravkalk"
ITVC980018A0 (it) Biscotti "le risaiole".
ITCS990004V0 (it) "termocamin0 c.c.m."

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application